Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Absci Corporation Common Stock
ABSI | US
3.15
USD0.15
5.00%
ABSI | US
About Absci Corporation Common Stock
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
01/04/2026
Close
3.15
Open
3.03
High
3.20
Low
3.03
Absci Corporation operates as a generative AI drug creation company in the United States. Its integrated drug creation platform identifies novel drug targets and creates biotherapeutic candidates. The company was founded in 2011 and is headquartered in Vancouver Washington.
View LessABSI | US
Risk
104.2
Sharpe
0.23
Luna's Score
43/100
Recommendation
Sell
Luna says (ABSI | US)
What's Working
Positive Momentum
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
77.1%1 month
104.2%3 months
87.7%6 months
100.4%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
2.12
Debt to equity
0.06
Debt to assets
0.05
Ent. to EBITDA
-0.39
Ent. to rev.
103.72
PEG
-
Other Fundamentals
EBITDA
-83.96M
MarketCap
357.70M
MarketCap(USD)
357.70M
Div. yield
-
Op. margin
-2.10K
Erngs. growth
-
Rev. growth
-62.30
Ret. on equity
-42.24
Short ratio
14.49
Short perc.
17.41
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
0.49
Range1M
0.96
Range3M
1.92
Volumes: Market Activity
Rel. volume
0.76
Price X volume
10.18M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.39 | - | Cheaper |
| Ent. to Revenue | 103.72 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 2.12 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 87.74 | - | Riskier |
| Debt to Equity | 0.06 | -1.23 | Expensive |
| Debt to Assets | 0.05 | 0.25 | Cheaper |
| Market Cap | 357.70M | - | Emerging |
